Intravenous Solutions (Colloids) Industry Research Report 2024

Intravenous Solutions (Colloids) Industry Research Report 2024


There are two types of IVFs, crystalloid and colloid solutions. Crystalloid solutions are used to treat most patients with shock from dengue, while colloids are reserved for patients with profound or refractory shock.

Highlights

The global Intravenous Solutions (Colloids) market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2025 and 2030.
Global Intravenous Solutions (Colloids) key players include ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous Solutions (Colloids), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Solutions (Colloids).
The Intravenous Solutions (Colloids) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravenous Solutions (Colloids) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravenous Solutions (Colloids) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

ICU Medical Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols S.A.

Product Type Insights

Global markets are presented by Intravenous Solutions (Colloids) type, along with growth forecasts through 2030. Estimates on sales and revenue are based on the price in the supply chain at which the Intravenous Solutions (Colloids) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).
Intravenous Solutions (Colloids) segment by Type

Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).
This report also outlines the market trends of each segment and consumer behaviors impacting the Intravenous Solutions (Colloids) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Intravenous Solutions (Colloids) market.
Intravenous Solutions (Colloids) segment by Application
Hospital and Clinics
Ambulatory
Home Care

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Intravenous Solutions (Colloids) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Solutions (Colloids) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Intravenous Solutions (Colloids) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Intravenous Solutions (Colloids) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Solutions (Colloids).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Intravenous Solutions (Colloids) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Intravenous Solutions (Colloids) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Intravenous Solutions (Colloids) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Intravenous Solutions (Colloids) Market Size (2019-2030) & (US$ Million)
2.2.2 Global Intravenous Solutions (Colloids) Sales (2019-2030)
2.2.3 Global Intravenous Solutions (Colloids) Market Average Price (2019-2030)
2.3 Intravenous Solutions (Colloids) by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
2.4 Intravenous Solutions (Colloids) by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Hospital and Clinics
2.4.3 Ambulatory
2.4.4 Home Care
3 Market Competitive Landscape by Manufacturers
3.1 Global Intravenous Solutions (Colloids) Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Intravenous Solutions (Colloids) Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Intravenous Solutions (Colloids) Revenue of Manufacturers (2019-2024)
3.4 Global Intravenous Solutions (Colloids) Average Price by Manufacturers (2019-2024)
3.5 Global Intravenous Solutions (Colloids) Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Intravenous Solutions (Colloids), Product Type & Application
3.8 Global Manufacturers of Intravenous Solutions (Colloids), Date of Enter into This Industry
3.9 Global Intravenous Solutions (Colloids) Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 ICU Medical Inc.
4.1.1 ICU Medical Inc. Company Information
4.1.2 ICU Medical Inc. Business Overview
4.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
4.1.4 ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
4.1.5 ICU Medical Inc. Recent Developments
4.2 B. Braun Melsungen AG
4.2.1 B. Braun Melsungen AG Company Information
4.2.2 B. Braun Melsungen AG Business Overview
4.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
4.2.4 B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
4.2.5 B. Braun Melsungen AG Recent Developments
4.3 Fresenius Kabi AG
4.3.1 Fresenius Kabi AG Company Information
4.3.2 Fresenius Kabi AG Business Overview
4.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
4.3.5 Fresenius Kabi AG Recent Developments
4.4 Baxter
4.4.1 Baxter Company Information
4.4.2 Baxter Business Overview
4.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Baxter Intravenous Solutions (Colloids) Product Portfolio
4.4.5 Baxter Recent Developments
4.5 Amanta Healthcare
4.5.1 Amanta Healthcare Company Information
4.5.2 Amanta Healthcare Business Overview
4.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
4.5.5 Amanta Healthcare Recent Developments
4.6 Terumo Medical Corporation
4.6.1 Terumo Medical Corporation Company Information
4.6.2 Terumo Medical Corporation Business Overview
4.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
4.6.4 Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
4.6.5 Terumo Medical Corporation Recent Developments
4.7 Grifols S.A.
4.7.1 Grifols S.A. Company Information
4.7.2 Grifols S.A. Business Overview
4.7.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
4.7.5 Grifols S.A. Recent Developments
5 Global Intravenous Solutions (Colloids) Market Scenario by Region
5.1 Global Intravenous Solutions (Colloids) Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Intravenous Solutions (Colloids) Sales by Region: 2019-2030
5.2.1 Global Intravenous Solutions (Colloids) Sales by Region: 2019-2024
5.2.2 Global Intravenous Solutions (Colloids) Sales by Region: 2025-2030
5.3 Global Intravenous Solutions (Colloids) Revenue by Region: 2019-2030
5.3.1 Global Intravenous Solutions (Colloids) Revenue by Region: 2019-2024
5.3.2 Global Intravenous Solutions (Colloids) Revenue by Region: 2025-2030
5.4 North America Intravenous Solutions (Colloids) Market Facts & Figures by Country
5.4.1 North America Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Intravenous Solutions (Colloids) Sales by Country (2019-2030)
5.4.3 North America Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Country
5.5.1 Europe Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Intravenous Solutions (Colloids) Sales by Country (2019-2030)
5.5.3 Europe Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Country
5.6.1 Asia Pacific Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Intravenous Solutions (Colloids) Sales by Country (2019-2030)
5.6.3 Asia Pacific Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Intravenous Solutions (Colloids) Market Facts & Figures by Country
5.7.1 Latin America Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Intravenous Solutions (Colloids) Sales by Country (2019-2030)
5.7.3 Latin America Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Country
5.8.1 Middle East and Africa Intravenous Solutions (Colloids) Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2019-2030)
5.8.3 Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Intravenous Solutions (Colloids) Sales by Type (2019-2030)
6.1.1 Global Intravenous Solutions (Colloids) Sales by Type (2019-2030) & (K Units)
6.1.2 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2019-2030)
6.2 Global Intravenous Solutions (Colloids) Revenue by Type (2019-2030)
6.2.1 Global Intravenous Solutions (Colloids) Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2019-2030)
6.3 Global Intravenous Solutions (Colloids) Price by Type (2019-2030)
7 Segment by Application
7.1 Global Intravenous Solutions (Colloids) Sales by Application (2019-2030)
7.1.1 Global Intravenous Solutions (Colloids) Sales by Application (2019-2030) & (K Units)
7.1.2 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2019-2030)
7.2 Global Intravenous Solutions (Colloids) Revenue by Application (2019-2030)
6.2.1 Global Intravenous Solutions (Colloids) Sales by Application (2019-2030) & (US$ Million)
6.2.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2019-2030)
7.3 Global Intravenous Solutions (Colloids) Price by Application (2019-2030)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Intravenous Solutions (Colloids) Value Chain Analysis
8.1.1 Intravenous Solutions (Colloids) Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Intravenous Solutions (Colloids) Production Mode & Process
8.2 Intravenous Solutions (Colloids) Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Intravenous Solutions (Colloids) Distributors
8.2.3 Intravenous Solutions (Colloids) Customers
9 Global Intravenous Solutions (Colloids) Analyzing Market Dynamics
9.1 Intravenous Solutions (Colloids) Industry Trends
9.2 Intravenous Solutions (Colloids) Industry Drivers
9.3 Intravenous Solutions (Colloids) Industry Opportunities and Challenges
9.4 Intravenous Solutions (Colloids) Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Intravenous Solutions (Colloids) Volume and Revenue Market Size and CAGR of Manufacturers (2019 Versus 2023)
Table 6. Global Intravenous Solutions (Colloids) Sales (K Units) of Manufacturers (2019-2024)
Table 7. Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2019-2024)
Table 8. Global Intravenous Solutions (Colloids) Revenue of Manufacturers (2019-2024)
Table 9. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers (2019-2024)
Table 10. Global Market Intravenous Solutions (Colloids) Average Price (USD/Unit) of Manufacturers (2019-2024)
Table 11. Global Intravenous Solutions (Colloids) Industry Ranking, 2022 VS 2023 VS 2024
Table 12. Global Manufacturers of Intravenous Solutions (Colloids), Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Solutions (Colloids) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. ICU Medical Inc. Company Information
Table 17. ICU Medical Inc. Business Overview
Table 18. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 19. ICU Medical Inc. Intravenous Solutions (Colloids) Product Portfolio
Table 20. ICU Medical Inc. Recent Developments
Table 21. B. Braun Melsungen AG Company Information
Table 22. B. Braun Melsungen AG Business Overview
Table 23. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 24. B. Braun Melsungen AG Intravenous Solutions (Colloids) Product Portfolio
Table 25. B. Braun Melsungen AG Recent Developments
Table 26. Fresenius Kabi AG Company Information
Table 27. Fresenius Kabi AG Business Overview
Table 28. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 29. Fresenius Kabi AG Intravenous Solutions (Colloids) Product Portfolio
Table 30. Fresenius Kabi AG Recent Developments
Table 31. Baxter Company Information
Table 32. Baxter Business Overview
Table 33. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 34. Baxter Intravenous Solutions (Colloids) Product Portfolio
Table 35. Baxter Recent Developments
Table 36. Amanta Healthcare Company Information
Table 37. Amanta Healthcare Business Overview
Table 38. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 39. Amanta Healthcare Intravenous Solutions (Colloids) Product Portfolio
Table 40. Amanta Healthcare Recent Developments
Table 41. Terumo Medical Corporation Company Information
Table 42. Terumo Medical Corporation Business Overview
Table 43. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 44. Terumo Medical Corporation Intravenous Solutions (Colloids) Product Portfolio
Table 45. Terumo Medical Corporation Recent Developments
Table 46. Grifols S.A. Company Information
Table 47. Grifols S.A. Business Overview
Table 48. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Grifols S.A. Intravenous Solutions (Colloids) Product Portfolio
Table 50. Grifols S.A. Recent Developments
Table 51. Global Intravenous Solutions (Colloids) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 52. Global Intravenous Solutions (Colloids) Sales by Region (2019-2024) & (K Units)
Table 53. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2019-2024)
Table 54. Global Intravenous Solutions (Colloids) Sales by Region (2025-2030) & (K Units)
Table 55. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2025-2030)
Table 56. Global Intravenous Solutions (Colloids) Revenue by Region (2019-2024) & (US$ Million)
Table 57. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2019-2024)
Table 58. Global Intravenous Solutions (Colloids) Revenue by Region (2025-2030) & (US$ Million)
Table 59. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2025-2030)
Table 60. North America Intravenous Solutions (Colloids) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. North America Intravenous Solutions (Colloids) Sales by Country (2019-2024) & (K Units)
Table 62. North America Intravenous Solutions (Colloids) Sales by Country (2025-2030) & (K Units)
Table 63. North America Intravenous Solutions (Colloids) Revenue by Country (2019-2024) & (US$ Million)
Table 64. North America Intravenous Solutions (Colloids) Revenue by Country (2025-2030) & (US$ Million)
Table 65. Europe Intravenous Solutions (Colloids) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 66. Europe Intravenous Solutions (Colloids) Sales by Country (2019-2024) & (K Units)
Table 67. Europe Intravenous Solutions (Colloids) Sales by Country (2025-2030) & (K Units)
Table 68. Europe Intravenous Solutions (Colloids) Revenue by Country (2019-2024) & (US$ Million)
Table 69. Europe Intravenous Solutions (Colloids) Revenue by Country (2025-2030) & (US$ Million)
Table 70. Asia Pacific Intravenous Solutions (Colloids) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Asia Pacific Intravenous Solutions (Colloids) Sales by Country (2019-2024) & (K Units)
Table 72. Asia Pacific Intravenous Solutions (Colloids) Sales by Country (2025-2030) & (K Units)
Table 73. Asia Pacific Intravenous Solutions (Colloids) Revenue by Country (2019-2024) & (US$ Million)
Table 74. Asia Pacific Intravenous Solutions (Colloids) Revenue by Country (2025-2030) & (US$ Million)
Table 75. Latin America Intravenous Solutions (Colloids) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 76. Latin America Intravenous Solutions (Colloids) Sales by Country (2019-2024) & (K Units)
Table 77. Latin America Intravenous Solutions (Colloids) Sales by Country (2025-2030) & (K Units)
Table 78. Latin America Intravenous Solutions (Colloids) Revenue by Country (2019-2024) & (US$ Million)
Table 79. Latin America Intravenous Solutions (Colloids) Revenue by Country (2025-2030) & (US$ Million)
Table 80. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 81. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2019-2024) & (K Units)
Table 82. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2025-2030) & (K Units)
Table 83. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2019-2024) & (US$ Million)
Table 84. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2025-2030) & (US$ Million)
Table 85. Global Intravenous Solutions (Colloids) Sales by Type (2019-2024) & (K Units)
Table 86. Global Intravenous Solutions (Colloids) Sales by Type (2025-2030) & (K Units)
Table 87. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2019-2024)
Table 88. Global Intravenous Solutions (Colloids) Sales Market Share by Type (2025-2030)
Table 89. Global Intravenous Solutions (Colloids) Revenue by Type (2019-2024) & (US$ Million)
Table 90. Global Intravenous Solutions (Colloids) Revenue by Type (2025-2030) & (US$ Million)
Table 91. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2019-2024)
Table 92. Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2025-2030)
Table 93. Global Intravenous Solutions (Colloids) Price by Type (2019-2024) & (USD/Unit)
Table 94. Global Intravenous Solutions (Colloids) Price by Type (2025-2030) & (USD/Unit)
Table 95. Global Intravenous Solutions (Colloids) Sales by Application (2019-2024) & (K Units)
Table 96. Global Intravenous Solutions (Colloids) Sales by Application (2025-2030) & (K Units)
Table 97. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2019-2024)
Table 98. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2025-2030)
Table 99. Global Intravenous Solutions (Colloids) Revenue by Application (2019-2024) & (US$ Million)
Table 100. Global Intravenous Solutions (Colloids) Revenue by Application (2025-2030) & (US$ Million)
Table 101. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2019-2024)
Table 102. Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2025-2030)
Table 103. Global Intravenous Solutions (Colloids) Price by Application (2019-2024) & (USD/Unit)
Table 104. Global Intravenous Solutions (Colloids) Price by Application (2025-2030) & (USD/Unit)
Table 105. Key Raw Materials
Table 106. Raw Materials Key Suppliers
Table 107. Intravenous Solutions (Colloids) Distributors List
Table 108. Intravenous Solutions (Colloids) Customers List
Table 109. Intravenous Solutions (Colloids) Industry Trends
Table 110. Intravenous Solutions (Colloids) Industry Drivers
Table 111. Intravenous Solutions (Colloids) Industry Restraints
Table 112. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Intravenous Solutions (Colloids)Product Picture
Figure 5. Global Intravenous Solutions (Colloids) Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 6. Global Intravenous Solutions (Colloids) Market Size (2019-2030) & (US$ Million)
Figure 7. Global Intravenous Solutions (Colloids) Sales (2019-2030) & (K Units)
Figure 8. Global Intravenous Solutions (Colloids) Average Price (USD/Unit) & (2019-2030)
Figure 9. Peripheral Parenteral Nutrition Product Picture
Figure 10. Total Parenteral Nutrition Product Picture
Figure 11. Hospital and Clinics Product Picture
Figure 12. Ambulatory Product Picture
Figure 13. Home Care Product Picture
Figure 14. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers in 2023
Figure 15. Global Manufacturers of Intravenous Solutions (Colloids), Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Intravenous Solutions (Colloids), Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Intravenous Solutions (Colloids) Players Market Share by Revenue in 2023
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Intravenous Solutions (Colloids) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. Global Intravenous Solutions (Colloids) Sales by Region in 2023
Figure 21. Global Intravenous Solutions (Colloids) Revenue by Region in 2023
Figure 22. North America Intravenous Solutions (Colloids) Market Size by Country in 2023
Figure 23. North America Intravenous Solutions (Colloids) Sales Market Share by Country (2019-2030)
Figure 24. North America Intravenous Solutions (Colloids) Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Intravenous Solutions (Colloids) Market Size by Country in 2023
Figure 28. Europe Intravenous Solutions (Colloids) Sales Market Share by Country (2019-2030)
Figure 29. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country (2019-2030)
Figure 30. Germany Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Intravenous Solutions (Colloids) Market Size by Country in 2023
Figure 36. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Country (2019-2030)
Figure 37. Asia Pacific Intravenous Solutions (Colloids) Revenue Market Share by Country (2019-2030)
Figure 38. China Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Intravenous Solutions (Colloids) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Latin America Intravenous Solutions (Colloids) Market Size by Country in 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings